These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17717436)

  • 1. The androgen receptor in prostate cancer: therapy target in search of an integrated diagnostic test.
    Ross JS
    Adv Anat Pathol; 2007 Sep; 14(5):353-7. PubMed ID: 17717436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.
    Vis AN; Schröder FH
    BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone treatment for prostate cancer: current issues and future directions.
    Ichikawa T; Suzuki H; Ueda T; Komiya A; Imamoto T; Kojima S
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():58-63. PubMed ID: 16273367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen axis in prostate cancer.
    Culig Z; Bartsch G
    J Cell Biochem; 2006 Oct; 99(2):373-81. PubMed ID: 16598769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
    Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
    Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino-terminus domain of the androgen receptor as a molecular target to prevent the hormonal progression of prostate cancer.
    Wang G; Sadar MD
    J Cell Biochem; 2006 May; 98(1):36-53. PubMed ID: 16440300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug insight: role of the androgen receptor in the development and progression of prostate cancer.
    Taplin ME
    Nat Clin Pract Oncol; 2007 Apr; 4(4):236-44. PubMed ID: 17392714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modelling of the androgen receptor axis: rational basis for androgen receptor intervention in androgen-independent prostate cancer.
    Fletterick RJ
    BJU Int; 2005 Dec; 96 Suppl 2():2-9. PubMed ID: 16359432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor amplification is associated with increased cell proliferation in prostate cancer.
    Haapala K; Kuukasjärvi T; Hyytinen E; Rantala I; Helin HJ; Koivisto PA
    Hum Pathol; 2007 Mar; 38(3):474-8. PubMed ID: 17217995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor: role and novel therapeutic prospects in prostate cancer.
    Taplin ME
    Expert Rev Anticancer Ther; 2008 Sep; 8(9):1495-508. PubMed ID: 18759700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen deprivation therapy for prostate cancer: current status and future prospects.
    Miyamoto H; Messing EM; Chang C
    Prostate; 2004 Dec; 61(4):332-53. PubMed ID: 15389811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Castration-resistant prostate cancer: locking up the molecular escape routes.
    Attar RM; Takimoto CH; Gottardis MM
    Clin Cancer Res; 2009 May; 15(10):3251-5. PubMed ID: 19447877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells.
    Gravina GL; Festuccia C; Millimaggi D; Dolo V; Tombolini V; de Vito M; Vicentini C; Bologna M
    Prostate; 2008 May; 68(7):793-801. PubMed ID: 18324645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen signaling and its interactions with other signaling pathways in prostate cancer.
    Kaarbø M; Klokk TI; Saatcioglu F
    Bioessays; 2007 Dec; 29(12):1227-38. PubMed ID: 18008377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer.
    Brown RS; Edwards J; Dogan A; Payne H; Harland SJ; Bartlett JM; Masters JR
    J Pathol; 2002 Oct; 198(2):237-44. PubMed ID: 12237884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and clinical utility of abiraterone acetate as an androgen synthesis inhibitor.
    Bryce A; Ryan CJ
    Clin Pharmacol Ther; 2012 Jan; 91(1):101-8. PubMed ID: 22130117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GnRH receptor and androgen receptor status and outcome of advanced prostate carcinomas.
    Szabó J; Bartók K; Krenács T; Szepesváry Z; Szende B
    Anticancer Res; 2009 Feb; 29(2):681-4. PubMed ID: 19331222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo amplification of the androgen receptor gene and progression of human prostate cancer.
    Visakorpi T; Hyytinen E; Koivisto P; Tanner M; Keinänen R; Palmberg C; Palotie A; Tammela T; Isola J; Kallioniemi OP
    Nat Genet; 1995 Apr; 9(4):401-6. PubMed ID: 7795646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleiotropic functional properties of androgen receptor mutants in prostate cancer.
    Bergerat JP; Céraline J
    Hum Mutat; 2009 Feb; 30(2):145-57. PubMed ID: 18800375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The case for secondary hormonal therapies in the chemotherapy age.
    Small EJ; Ryan CJ
    J Urol; 2006 Dec; 176(6 Pt 2):S66-71. PubMed ID: 17084172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.